Arteriovenous Fistula of the Peroneal Artery Complicating a Retrograde Access: Successful Endovascular Treatment with Covered Stent Implantation

2020 ◽  
Vol 64 ◽  
pp. 410.e1-410.e6
Author(s):  
Gabriele Testi ◽  
Simone Grotti ◽  
Tanja Ceccacci ◽  
Fabio Tarantino ◽  
Giorgio Ubaldo Turicchia
Keyword(s):  
Endovascular Treatment ◽  
Arteriovenous Fistula ◽  
Stent Implantation ◽  
Covered Stent ◽  
Peroneal Artery

scholarly journals Traumatic arteriovenous fistula: a 25-year delay in presentation

2020 ◽  
Vol 2020 (3) ◽  
Author(s):  
Alexandra Stathis ◽  
John Gan
Keyword(s):  
Endovascular Treatment ◽  
Arteriovenous Fistula ◽  
Popliteal Artery ◽  
Stab Wound ◽  
Duplex Ultrasound ◽  
Posterior Tibial Artery ◽  
Covered Stent ◽  
Delayed Presentation ◽  
Posterior Tibial ◽  
History Of

Abstract A 64-year-old lady presented with a 6-month history of worsening unilateral leg swelling, with an audible bruit of the popliteal artery. Arterial duplex ultrasound confirmed the presence of an arteriovenous fistula (AVF) between the posterior tibial artery and vein. Upon thorough history, it was discovered that the patient had sustained a stab wound to this region some 25 years prior. The fistula was successfully managed endovascularly by means of a covered stent. This case highlights an unusual delayed presentation of an AVF and demonstrates the effectiveness of endovascular treatment of this condition.

scholarly journals Anatomically Based Approach for Endovascular Treatment of Vertebro-Vertebral Arteriovenous Fistula

2014 ◽  
Vol 20 (6) ◽  
pp. 766-773 ◽  
Author(s):  
Chih-Hua Yeh ◽  
Yao-Liang Chen ◽  
Yi-Ming Wu ◽  
Yu-Chieh Huang ◽  
Ho-Fai Wong
Keyword(s):  
Endovascular Treatment ◽  
Vertebral Artery ◽  
Arteriovenous Fistula ◽  
Covered Stent ◽  
Treatment Modalities ◽  
Covered Stents ◽  
Vertebral Arteriovenous Fistula ◽  
Fistula Recurrence ◽  
Detachable Coils ◽  
Extracranial Vertebral Artery

Vertebro-vertebral arteriovenous fistula (VV-AVF) is a rare vascular disorder with an abnormal high-flow shunt between the extracranial vertebral artery (VA), its muscular or radicular branches and an adjacent vein. To date, there are no guidelines on the best treatment for VV-AVF. We present our experience of VV-AVF treatment with covered stents in three patients and detachable coils in two patients. One patient with fistula at the V3 segment had rapid fistula recurrence one week after covered stent treatment. The possible causes of failed treatment in this patient are discussed. The currently available treatment modalities for VV-AVF are also summarized after a literature review. At the end of this article, we propose a new concept of anatomically based approach for endovascular treatment of VV-AVF. Fistula in the V1-2 segments of vertebral artery could be treated safely and effectively by covered stent with the benefit of preserving VA patency. Embolization with variable embolizers should be considered first for fistula in the V3 segment because of the tortuous course and flexibility of the VA in this segment.

scholarly journals Successful Endovascular Treatment with Covered Stent for Iatrogenic Vertebral Arteriovenous Fistula

2018 ◽  
Vol 12 (1) ◽  
pp. 29-37 ◽  
Author(s):  
Takuya Okata ◽  
Akira Ishii ◽  
Nobutake Sadamasa ◽  
Yasutoshi Kai ◽  
Ryota Ishibashi ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Arteriovenous Fistula ◽  
Covered Stent ◽  
Vertebral Arteriovenous Fistula

Endovascular Treatment of Arteriovenous Fistula with Pseudoaneurysm at Popliteal Fossa Using a PTFE Stent-graft: A Case Report

2005 ◽  
Vol 52 (2) ◽  
pp. 107
Author(s):  
Jeong Yeol Choi ◽  
Dong Hyun Kim ◽  
Hyung Woo Oh ◽  
Jeong Hwan Jang ◽  
Jae Hee Oh ◽  
...  
Keyword(s):  
Case Report ◽  
Endovascular Treatment ◽  
Arteriovenous Fistula ◽  
Stent Graft ◽  
Popliteal Fossa

Transbrachial and transfemoral approaches combined with visceral protection for the treatment of juxtarenal aortoiliac occlusive disease: Technical issues and clinical outcomes

Vascular ◽  
2021 ◽  
pp. 170853812110232
Author(s):  
Peixian Gao ◽  
Changliang Li ◽  
Xuejun Wu ◽  
Gang Li ◽  
Dianning Dong ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Bare Metal Stents ◽  
Covered Stent ◽  
Occlusive Disease ◽  
Metal Stents ◽  
Infrarenal Aorta ◽  
Bare Metal ◽  
Stent Grafts ◽  
Aortoiliac Occlusive Disease

Purpose To evaluate the safety and efficacy of transbrachial and transfemoral approaches combined with visceral protection for the endovascular treatment of juxtarenal aortoiliac occlusive disease (AIOD) over an average 19-month follow-up period. Methods In this retrospective analysis, all patients with juxtarenal AIOD at a single institution were reviewed from June 2015 to January 2020. Patient characteristics, angiographic results, and follow-up outcomes were retrospectively recorded. The indications for treatment were critical limb threatening ischemia in 12 patients and bilateral claudication in five patients. Percutaneous access via the left brachial artery was first obtained to recanalize the infrarenal occluded lesions. After that, femoral accesses were achieved. A 4-Fr catheter, a 4 mm balloon, or a 6-Fr 90-cm-long sheath was used to complete visceral artery protection. Results A total of 17 juxtarenal AIOD patients (14 males; mean age, 63.4 ± 8.1 years) underwent endovascular treatment. The technical success rate was 100%. Complete reconstruction was achieved in 15 (88.2%) patients. The infrarenal aorta was reconstructed with kissing covered stent grafts ( n = 7), kissing bare-metal stents ( n = 2), covered stent grafts ( n = 2), bare-metal stents ( n = 1), or the off-label use of iliac limb stent grafts ( n = 5). Renal embolization was found in 3 (17.6%) patients during intraoperative angiography. There was 1 (5.9%) case of distal runoff embolization after CDT and 1 (5.9%) case of left iliac artery rupture. One (5.9%) death occurred due to acute myocardial infarction 20 days after the operation. The average follow-up period was 19.3 ± 16.7 months (range, 1–54 months) in the remaining 16 cases. The renal artery patency rate was 100%. The estimated cumulative primary patency rates were 92.3% at 12 months and 59.3% at 36 months according to the Kaplan–Meier method. Conclusions Transbrachial and transfemoral approaches combined with visceral protection offer a safe and effective alternative to open revascularization for the endovascular treatment of juxtarenal AIOD.

Sign in / Sign up

Export Citation Format

Share Document